Endurance Wealth Management’s Pediatrix Medical MD Stock Holding History

Endurance Wealth Management’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-400	Closed	-$29K	–	516
2015 Q4	$29K	Sell	400 -15,000	-97%	-$1.11M	0.01%	311
2015 Q3	$1.24M	Hold	15,400	–	–	0.22%	93
2015 Q2	$1.14M	Hold	15,400	–	–	0.19%	99
2015 Q1	$1.12M	Hold	15,400	–	–	0.19%	96
2014 Q4	$1.02M	Hold	15,400	–	–	0.18%	102
2014 Q3	$844K	Hold	15,400	–	–	0.16%	107
2014 Q2	$895K	Hold	15,400	–	–	0.15%	114
2014 Q1	$954K	Buy	15,400 +7,700	+100%	+$448K	0.19%	96
2013 Q4	$411K	Sell	7,700 -2,300	-23%	-$123K	0.08%	125
2013 Q3	$502K	Hold	10,000	–	–	0.11%	112
2013 Q2	$457K	Buy	+10,000	New	+$448K	0.1%	115

Other funds holding MD

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Endurance Wealth Management's MD Position: Q1 2016 in Review

Endurance Wealth Management sold out of Pediatrix Medical (MD) in Q1 2016, closing a stake of 400 shares — an estimated $29K sold.

Endurance Wealth Management first reported a position in MD in Q2 2013 and held it in 11 quarters. The position peaked at $1.24M in Q3 2015. 382 funds tracked by Wall St. Rank hold MD as of Q1 2016.

Endurance Wealth Management reported no remaining Pediatrix Medical position as of Q1 2016 after selling out during the quarter.
Endurance Wealth Management sold 400 Pediatrix Medical shares in Q1 2016, an estimated $29K.
Endurance Wealth Management first reported a position in Pediatrix Medical in Q2 2013 and held it in 11 quarters.
Endurance Wealth Management's Pediatrix Medical position peaked at $1.24M in Q3 2015.
382 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2016.

Based on Endurance Wealth Management's 13F filing for Q1 2016, filed 12 Apr 2016.